Fremskritt innen LSD-terapi, FDA-reverseringer, datakrasj

Kilder

• STAT: STAT+: Definium LSD therapy helped patients with major depression in late-stage trial
• Raps: Recon: AbbVie forges $10.9 billion deal with Apogee; US FDA changes tack on Regenxbio's rare disease gene therapy - RAPS.org
• Businesswire: Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder - Business Wire
• wikimedia: Photo by ANU TV / Wikimedia Commons / CC BY 3.0

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.